Deepa Jagadeesh

3.2k total citations
123 papers, 1.1k citations indexed

About

Deepa Jagadeesh is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Deepa Jagadeesh has authored 123 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pathology and Forensic Medicine, 62 papers in Oncology and 44 papers in Genetics. Recurrent topics in Deepa Jagadeesh's work include Lymphoma Diagnosis and Treatment (73 papers), Chronic Lymphocytic Leukemia Research (41 papers) and Hematopoietic Stem Cell Transplantation (24 papers). Deepa Jagadeesh is often cited by papers focused on Lymphoma Diagnosis and Treatment (73 papers), Chronic Lymphocytic Leukemia Research (41 papers) and Hematopoietic Stem Cell Transplantation (24 papers). Deepa Jagadeesh collaborates with scholars based in United States, Switzerland and Spain. Deepa Jagadeesh's co-authors include Andrew M. Evens, Brian T. Hill, Bruce A. Woda, Brad Pohlman, Robert M. Dean, Mitchell R. Smith, Lisa Rybicki, Navneet S. Majhail, Betty K. Hamilton and Ronald Sobecks and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Deepa Jagadeesh

114 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deepa Jagadeesh United States	17	660	652	273	172	170	123	1.1k
Wataru Munakata Japan	18	649 1.0×	459 0.7×	347 1.3×	173 1.0×	170 1.0×	103	1.1k
J. M. Vose United States	15	801 1.2×	596 0.9×	289 1.1×	198 1.2×	148 0.9×	34	1.2k
Daniele Laszlò Italy	20	649 1.0×	709 1.1×	350 1.3×	140 0.8×	223 1.3×	67	1.6k
Nicole Straetmans Belgium	17	546 0.8×	572 0.9×	333 1.2×	97 0.6×	151 0.9×	44	1.1k
José‐Tomás Navarro Spain	17	571 0.9×	583 0.9×	305 1.1×	165 1.0×	66 0.4×	85	964
Giuseppe Gritti Italy	17	628 1.0×	651 1.0×	298 1.1×	114 0.7×	392 2.3×	59	1.2k
Ronit Gurion Israel	17	344 0.5×	381 0.6×	216 0.8×	110 0.6×	102 0.6×	83	830
Daniel Espinouse France	19	584 0.9×	590 0.9×	356 1.3×	135 0.8×	181 1.1×	43	1.3k
Karin Hohloch Germany	13	460 0.7×	249 0.4×	314 1.2×	127 0.7×	208 1.2×	40	960
Riikka Räty Finland	18	883 1.3×	731 1.1×	484 1.8×	63 0.4×	92 0.5×	46	1.3k

Countries citing papers authored by Deepa Jagadeesh

Since Specialization

Citations

This map shows the geographic impact of Deepa Jagadeesh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepa Jagadeesh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepa Jagadeesh more than expected).

Fields of papers citing papers by Deepa Jagadeesh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepa Jagadeesh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepa Jagadeesh. The network helps show where Deepa Jagadeesh may publish in the future.

Co-authorship network of co-authors of Deepa Jagadeesh

This figure shows the co-authorship network connecting the top 25 collaborators of Deepa Jagadeesh. A scholar is included among the top collaborators of Deepa Jagadeesh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepa Jagadeesh. Deepa Jagadeesh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Wei, Meriel P Burns, Deepa Jagadeesh, et al.. (2025). Assessment of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplant When Comparing Treatment with and without Post-Transplant Cyclophosphamide. Transplantation and Cellular Therapy. 31(2). S372–S372. 1 indexed citations

Zhao, Xiaoxian, Deepa Jagadeesh, Juraj Bodo, et al.. (2025). Angioimmunoblastic T‐cell lymphoma: Characterization of clonal T and B cells and a patient‐derived xenograft study of coexisting T‐ and B‐cell proliferation. eJHaem. 6(1). e1080–e1080.

Hamilton, Betty K., Lisa Rybicki, Hong Li, et al.. (2023). Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention. Blood Advances. 7(16). 4505–4513. 4 indexed citations

Aleixo, Gabriel, Wei Wei, Po‐Hao Chen, et al.. (2023). The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma. Bone Marrow Transplantation. 58(12). 1384–1389. 2 indexed citations

Parameswaran, Neetha, Lingjun Zhang, Frank P. DiFilippo, et al.. (2023). CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma. Leukemia. 37(10). 2050–2057. 8 indexed citations

Urban, Theresa, Faiz Anwer, Robert M. Dean, et al.. (2022). Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring. Journal of Oncology Pharmacy Practice. 32(2). 184–188. 1 indexed citations

Mian, Agrima, Wei Wei, Brian T. Hill, et al.. (2021). Resource Utilization and Factors Prolonging Hospitalization for Patients with Refractory and Relapsed Large B-Cell Lymphoma Receiving Tisagenlecleucel Versus Axicabtagene Ciloleucel. Transplantation and Cellular Therapy. 27(3). S307–S307. 2 indexed citations

Rybicki, Lisa, Faiz Anwer, Robert M. Dean, et al.. (2021). Comparison of the Prognostic Value of Risk Assessment Tools in Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 27(3). S140–S141. 1 indexed citations

Sawalha, Yazeed, Tomas Radivoyevitch, Xuefei Jia, et al.. (2021). The impact of socioeconomic disparities on the use of upfront autologous stem cell transplantation for mantle cell lymphoma. Leukemia & lymphoma. 63(2). 335–343. 4 indexed citations

10.

Hill, Brian T., Deepa Jagadeesh, Brad Pohlman, et al.. (2020). A pilot clinical trial of oral tetrahydrouridine/decitabine for noncytotoxic epigenetic therapy of chemoresistant lymphoid malignancies. Seminars in Hematology. 58(1). 35–44. 8 indexed citations

11.

Hill, Brian T., Deepa Jagadeesh, Alex Garcia, et al.. (2020). Results of a Phase I Trial of Lenalidomide, Rituximab (R2) and Ixazomib for Frontline Treatment of High Risk Follicular and Indolent Non-Hodgkin Lymphoma. Blood. 136(Supplement 1). 1–2. 1 indexed citations

12.

Hong, Sanghee, Lisa Rybicki, Betty K. Hamilton, et al.. (2020). Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era. Hematology/Oncology and Stem Cell Therapy. 14(4). 318–326. 9 indexed citations

13.

Mian, Agrima, Wei Wei, Allison Winter, et al.. (2019). Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis. Blood. 134(Supplement_1). 4452–4452. 5 indexed citations

14.

Urban, Theresa, Robert M. Dean, Aaron T. Gerds, et al.. (2019). Evaluation of Corticosteroids for Engraftment Syndrome (ES) Prophylaxis in Patients Undergoing Autologous Hematopoietic Cell Transplantation (AHCT) with High-Dose Melphalan (MEL). Biology of Blood and Marrow Transplantation. 25(3). S281–S281. 1 indexed citations

15.

Patel, Sagar S., Lisa Rybicki, Dawn Thomas, et al.. (2019). Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation. Hematology/Oncology and Stem Cell Therapy. 13(1). 32–39. 6 indexed citations

16.

Rybicki, Lisa, Brian J. Bolwell, Mohamed A. Kharfan‐Dabaja, et al.. (2017). Conditional Long-Term Survival Among Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Autologous Hematopoietic Cell Transplantation (AHCT). Blood. 130. 3437–3437. 1 indexed citations

17.

Mukhija, Dhruvika, Tomas Radivoyevitch, Brian T. Hill, et al.. (2017). Outcomes in Patients with Enteropathy-Associated T-Cell Lymphoma (EATL) and Hepatosplenic T-Cell Lymphoma (HSTCL): A Population Based Analysis Using the SEER Data. Blood. 130. 2805–2805. 1 indexed citations

18.

Sawalha, Yazeed, Tomas Radivoyevitch, Katherine Tullio, et al.. (2017). The Role of Upfront Autologous Hematopoietic Cell Transplantation in the Treatment of Mantle Cell Lymphoma, a Population Based Study Using the National Cancer Data Base (NCDB). Blood. 130. 2009–2009. 5 indexed citations

19.

Sawalha, Yazeed, Brian T. Hill, Lisa Rybicki, et al.. (2017). Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience. Clinical Lymphoma Myeloma & Leukemia. 18(1). e95–e102. 5 indexed citations

20.

Jagadeesh, Deepa & Mitchell R. Smith. (2013). Novel targeted therapies in peripheral T cell lymphoma.. PubMed. 15(85). 367–78. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact